📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

P99 The value of oral prednisolone in patients with severe eosinophilic asthma on mepolizumab treatment (2021)

First Author: Yang J

Attributed to: United Kingdom Refractory Asthma Stratification Programme (RASP-UK) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/thorax-2020-btsabstracts.244

Publication URI: http://dx.doi.org/10.1136/thorax-2020-btsabstracts.244

Type: Conference/Paper/Proceeding/Abstract